ABIGAIL CLARK: Open Payments
NPI 1376138289 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $725 · 2025 $1,292
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 6 | $567 |
| W. L. Gore & Associates, Inc. | 5 | $266 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Bolton Medical Inc | 1 | $62 |
| Boston Scientific Corporation | 1 | $57 |
| Lilly USA, LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $54 |
| Novo Nordisk Inc | 3 | $52 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: ARTIX MT, EXCLUDER Conformable AAA Endoprosthesis with Active Control, AIRSUPRA, GORE VIABAHN Endoprosthesis with Heparin, Kerendia, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ENROUTE Transcarotid Stent, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
